---
title: "Riluzole Oral Suspension (Tiglutik) Shortage: Manufacturing Issues Impact Availability"
summary: "The FDA reports a shortage of Riluzole Oral Suspension (Tiglutik) due to manufacturing interruptions, though some Teglutik presentations remain available."
category: "drug-shortages"
tags: ["drug-shortage","fda","medication","Riluzole","Oral-Suspension"]
location: "United States"
severity: "medium"
sourceUrl: "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
sourceAgency: "FDA"
publishedAt: 2026-02-11T19:16:38.000Z
---
### What's in Shortage

Riluzole Oral Suspension, a medication categorized for use in neurology, is currently listed in the FDA drug shortage database. This shortage affects specific presentations of the brand-name medications TEGLUTIK and TIGLUTIK. While some concentrations remain available, the 50 mg/10 mL presentation of Tiglutik is currently unavailable.

### Which Manufacturers Are Affected

**EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.)**

The following presentations are currently **Available**:
- Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0304-1)
- Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0305-1)
- Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0306-1)

The following presentation is currently **Unavailable**:
- Tiglutik, Oral Suspension, 50 mg/10 mL (NDC 70726-0303-2)

Patients or providers with questions can contact the manufacturer directly at 610-937-6172.

### Why There's a Shortage

According to the manufacturer, the shortage of the Tiglutik 50 mg/10 mL presentation is due to a product manufacturing interruption related to viscosity testing. A date for the next product release is not available at this time.

### What Patients Should Do

If you are currently prescribed Riluzole Oral Suspension, please consider the following steps:
- **Consult your healthcare provider:** Discuss the current availability and how it may impact your specific treatment plan.
- **Speak with your pharmacist:** Inquire about the stock status of the available 5 mg/1 mL presentations.
- **Contact the manufacturer:** You may call EDW Pharma, Inc. at 610-937-6172 for updates regarding supply timelines.

*Disclaimer: Patients should always consult their healthcare provider or pharmacist regarding medication changes or treatment concerns.*

### Source

Information provided by the FDA Drug Shortage Database.  
**Initial Posting Date:** 01/26/2024  
**Last Updated:** 02/02/2026